650 related articles for article (PubMed ID: 19709553)
1. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma].
Avilés-Izquierdo JA; Lázaro-Ochaita P
Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
3. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
4. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
7. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymph node biopsy in patients with melanoma].
Tomás-Mallebrera L; Rojo-España R; Marquina-Vila A; Gimeno-Clemente N; Morales-Suárez-Varela MM
Actas Dermosifiliogr; 2010 Jun; 101(5):428-36. PubMed ID: 20525486
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.
Koskivuo I; Hernberg M; Vihinen P; Virolainen S; Talve L; Seppänen M; Vahlberg T; Jahkola T
Br J Surg; 2011 Oct; 98(10):1400-7. PubMed ID: 21638276
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
13. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM
Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up.
Mozzillo N; Caracò C; Chiofalo MG; Celentano E; Lastoria S; Botti G; Ascierto PA
Eur J Surg Oncol; 2004 May; 30(4):440-3. PubMed ID: 15063899
[TBL] [Abstract][Full Text] [Related]
17. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
Kruit WH;
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
[TBL] [Abstract][Full Text] [Related]
18. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy.
Yee VS; Thompson JF; McKinnon JG; Scolyer RA; Li LX; McCarthy WH; O'Brien CJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF
Ann Surg Oncol; 2005 Jun; 12(6):429-39. PubMed ID: 15886905
[TBL] [Abstract][Full Text] [Related]
19. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ
Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753
[TBL] [Abstract][Full Text] [Related]
20. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR;
Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
